Click for best price
Nasal Drug Delivery Technology Market Size, Share 2023
| Market size in 2022 |
US$ 56110 million
|
Forecast Market size by 2029 |
US$ 75180 million
|
| Growth Rate |
CAGR of 4.3% |
Number of Pages |
102 Pages |
The global Nasal Drug Delivery Technology market was valued at US$ 56110 million in 2022 and is projected to reach US$ 75180 million by 2029, at a CAGR of 4.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Nasal Drug Delivery Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nasal Drug Delivery Technology. This report contains market size and forecasts of Nasal Drug Delivery Technology in global, including the following market information:
- Global Nasal Drug Delivery Technology Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Pressurized Type Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Nasal Drug Delivery Technology include 3M United States, Aegis Therapeutics LLC, Aptargroup, Inc., Becton, Dickinson and Company, BF Ascher & Company, Inc., Cadila Pharmaceuticals Ltd, Dickinson and Company, Douglas Pharmaceuticals Ltd and ENT Technologies Pty. Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nasal Drug Delivery Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nasal Drug Delivery Technology Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Nasal Drug Delivery Technology Market Segment Percentages, by Type, 2022 (%)
- Pressurized Type
- Non-pressurized Type
Global Nasal Drug Delivery Technology Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Nasal Drug Delivery Technology Market Segment Percentages, by Application, 2022 (%)
- Nasal Congestion
- Rhinitis
- Asthma
- Other
Global Nasal Drug Delivery Technology Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Nasal Drug Delivery Technology Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Nasal Drug Delivery Technology revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Nasal Drug Delivery Technology revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- 3M United States
- Aegis Therapeutics LLC
- Aptargroup, Inc.
- Becton, Dickinson and Company
- BF Ascher & Company, Inc.
- Cadila Pharmaceuticals Ltd
- Dickinson and Company
- Douglas Pharmaceuticals Ltd
- ENT Technologies Pty. Ltd
- Glaxosmithkline PLC
- Johnson & Johnson
- Merck & Co., Inc.
- Novartis AG
- OptiNose, Inc
- PendoPharm, Inc
- Pfizer, Inc
- Promius Pharma, LLC
- Shin Nippon Biomedical Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nasal Drug Delivery Technology, market overview.
Chapter 2: Global Nasal Drug Delivery Technology market size in revenue.
Chapter 3: Detailed analysis of Nasal Drug Delivery Technology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nasal Drug Delivery Technology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Nasal Drug Delivery Technology Market, Global Outlook and Forecast 2023-2032 |
| Market size in 2022 |
US$ 56110 million
|
| Forecast Market size by 2029 |
US$ 75180 million
|
| Growth Rate |
CAGR of 4.3% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
102 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nasal Drug Delivery Technology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nasal Drug Delivery Technology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nasal Drug Delivery Technology Overall Market Size
2.1 Global Nasal Drug Delivery Technology Market Size: 2022 VS 2032
2.2 Global Nasal Drug Delivery Technology Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nasal Drug Delivery Technology Players in Global Market
3.2 Top Global Nasal Drug Delivery Technology Companies Ranked by Revenue
3.3 Global Nasal Drug Delivery Technology Revenue by Companies
3.4 Top 3 and Top 5 Nasal Drug Delivery Technology Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nasal Drug Delivery Technology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nasal Drug Delivery Technology Players in Global Market
3.6.1 List of Global Tier 1 Nasal Drug Delivery Technology Companies
3.6.2 List of Global Tier 2 and Tier 3 Nasal Drug Delivery Technology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Nasal Drug Delivery Technology Market Size Markets, 2022 & 2032
4.1.2 Pressurized Type
4.1.3 Non-pressurized Type
4.2 By Type - Global Nasal Drug Delivery Technology Revenue & Forecasts
4.2.1 By Type - Global Nasal Drug Delivery Technology Revenue, 2018-2023
4.2.2 By Type - Global Nasal Drug Delivery Technology Revenue, 2024-2032
4.2.3 By Type - Global Nasal Drug Delivery Technology Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nasal Drug Delivery Technology Market Size, 2022 & 2032
5.1.2 Nasal Congestion
5.1.3 Rhinitis
5.1.4 Asthma
5.1.5 Other
5.2 By Application - Global Nasal Drug Delivery Technology Revenue & Forecasts
5.2.1 By Application - Global Nasal Drug Delivery Technology Revenue, 2018-2023
5.2.2 By Application - Global Nasal Drug Delivery Technology Revenue, 2024-2032
5.2.3 By Application - Global Nasal Drug Delivery Technology Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Nasal Drug Delivery Technology Market Size, 2022 & 2032
6.2 By Region - Global Nasal Drug Delivery Technology Revenue & Forecasts
6.2.1 By Region - Global Nasal Drug Delivery Technology Revenue, 2018-2023
6.2.2 By Region - Global Nasal Drug Delivery Technology Revenue, 2024-2032
6.2.3 By Region - Global Nasal Drug Delivery Technology Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Nasal Drug Delivery Technology Revenue, 2018-2032
6.3.2 US Nasal Drug Delivery Technology Market Size, 2018-2032
6.3.3 Canada Nasal Drug Delivery Technology Market Size, 2018-2032
6.3.4 Mexico Nasal Drug Delivery Technology Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Nasal Drug Delivery Technology Revenue, 2018-2032
6.4.2 Germany Nasal Drug Delivery Technology Market Size, 2018-2032
6.4.3 France Nasal Drug Delivery Technology Market Size, 2018-2032
6.4.4 U.K. Nasal Drug Delivery Technology Market Size, 2018-2032
6.4.5 Italy Nasal Drug Delivery Technology Market Size, 2018-2032
6.4.6 Russia Nasal Drug Delivery Technology Market Size, 2018-2032
6.4.7 Nordic Countries Nasal Drug Delivery Technology Market Size, 2018-2032
6.4.8 Benelux Nasal Drug Delivery Technology Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Nasal Drug Delivery Technology Revenue, 2018-2032
6.5.2 China Nasal Drug Delivery Technology Market Size, 2018-2032
6.5.3 Japan Nasal Drug Delivery Technology Market Size, 2018-2032
6.5.4 South Korea Nasal Drug Delivery Technology Market Size, 2018-2032
6.5.5 Southeast Asia Nasal Drug Delivery Technology Market Size, 2018-2032
6.5.6 India Nasal Drug Delivery Technology Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Nasal Drug Delivery Technology Revenue, 2018-2032
6.6.2 Brazil Nasal Drug Delivery Technology Market Size, 2018-2032
6.6.3 Argentina Nasal Drug Delivery Technology Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nasal Drug Delivery Technology Revenue, 2018-2032
6.7.2 Turkey Nasal Drug Delivery Technology Market Size, 2018-2032
6.7.3 Israel Nasal Drug Delivery Technology Market Size, 2018-2032
6.7.4 Saudi Arabia Nasal Drug Delivery Technology Market Size, 2018-2032
6.7.5 UAE Nasal Drug Delivery Technology Market Size, 2018-2032
7 Nasal Drug Delivery Technology Companies Profiles
7.1 3M United States
7.1.1 3M United States Company Summary
7.1.2 3M United States Business Overview
7.1.3 3M United States Nasal Drug Delivery Technology Major Product Offerings
7.1.4 3M United States Nasal Drug Delivery Technology Revenue in Global Market (2018-2023)
7.1.5 3M United States Key News & Latest Developments
7.2 Aegis Therapeutics LLC
7.2.1 Aegis Therapeutics LLC Company Summary
7.2.2 Aegis Therapeutics LLC Business Overview
7.2.3 Aegis Therapeutics LLC Nasal Drug Delivery Technology Major Product Offerings
7.2.4 Aegis Therapeutics LLC Nasal Drug Delivery Technology Revenue in Global Market (2018-2023)
7.2.5 Aegis Therapeutics LLC Key News & Latest Developments
7.3 Aptargroup, Inc.
7.3.1 Aptargroup, Inc. Company Summary
7.3.2 Aptargroup, Inc. Business Overview
7.3.3 Aptargroup, Inc. Nasal Drug Delivery Technology Major Product Offerings
7.3.4 Aptargroup, Inc. Nasal Drug Delivery Technology Revenue in Global Market (2018-2023)
7.3.5 Aptargroup, Inc. Key News & Latest Developments
7.4 Becton, Dickinson and Company
7.4.1 Becton, Dickinson and Company Company Summary
7.4.2 Becton, Dickinson and Company Business Overview
7.4.3 Becton, Dickinson and Company Nasal Drug Delivery Technology Major Product Offerings
7.4.4 Becton, Dickinson and Company Nasal Drug Delivery Technology Revenue in Global Market (2018-2023)
7.4.5 Becton, Dickinson and Company Key News & Latest Developments
7.5 BF Ascher & Company, Inc.
7.5.1 BF Ascher & Company, Inc. Company Summary
7.5.2 BF Ascher & Company, Inc. Business Overview
7.5.3 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Major Product Offerings
7.5.4 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Revenue in Global Market (2018-2023)
7.5.5 BF Ascher & Company, Inc. Key News & Latest Developments
7.6 Cadila Pharmaceuticals Ltd
7.6.1 Cadila Pharmaceuticals Ltd Company Summary
7.6.2 Cadila Pharmaceuticals Ltd Business Overview
7.6.3 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Major Product Offerings
7.6.4 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue in Global Market (2018-2023)
7.6.5 Cadila Pharmaceuticals Ltd Key News & Latest Developments
7.7 Dickinson and Company
7.7.1 Dickinson and Company Company Summary
7.7.2 Dickinson and Company Business Overview
7.7.3 Dickinson and Company Nasal Drug Delivery Technology Major Product Offerings
7.7.4 Dickinson and Company Nasal Drug Delivery Technology Revenue in Global Market (2018-2023)
7.7.5 Dickinson and Company Key News & Latest Developments
7.8 Douglas Pharmaceuticals Ltd
7.8.1 Douglas Pharmaceuticals Ltd Company Summary
7.8.2 Douglas Pharmaceuticals Ltd Business Overview
7.8.3 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Major Product Offerings
7.8.4 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue in Global Market (2018-2023)
7.8.5 Douglas Pharmaceuticals Ltd Key News & Latest Developments
7.9 ENT Technologies Pty. Ltd
7.9.1 ENT Technologies Pty. Ltd Company Summary
7.9.2 ENT Technologies Pty. Ltd Business Overview
7.9.3 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Major Product Offerings
7.9.4 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Revenue in Global Market (2018-2023)
7.9.5 ENT Technologies Pty. Ltd Key News & Latest Developments
7.10 Glaxosmithkline PLC
7.10.1 Glaxosmithkline PLC Company Summary
7.10.2 Glaxosmithkline PLC Business Overview
7.10.3 Glaxosmithkline PLC Nasal Drug Delivery Technology Major Product Offerings
7.10.4 Glaxosmithkline PLC Nasal Drug Delivery Technology Revenue in Global Market (2018-2023)
7.10.5 Glaxosmithkline PLC Key News & Latest Developments
7.11 Johnson & Johnson
7.11.1 Johnson & Johnson Company Summary
7.11.2 Johnson & Johnson Business Overview
7.11.3 Johnson & Johnson Nasal Drug Delivery Technology Major Product Offerings
7.11.4 Johnson & Johnson Nasal Drug Delivery Technology Revenue in Global Market (2018-2023)
7.11.5 Johnson & Johnson Key News & Latest Developments
7.12 Merck & Co., Inc.
7.12.1 Merck & Co., Inc. Company Summary
7.12.2 Merck & Co., Inc. Business Overview
7.12.3 Merck & Co., Inc. Nasal Drug Delivery Technology Major Product Offerings
7.12.4 Merck & Co., Inc. Nasal Drug Delivery Technology Revenue in Global Market (2018-2023)
7.12.5 Merck & Co., Inc. Key News & Latest Developments
7.13 Novartis AG
7.13.1 Novartis AG Company Summary
7.13.2 Novartis AG Business Overview
7.13.3 Novartis AG Nasal Drug Delivery Technology Major Product Offerings
7.13.4 Novartis AG Nasal Drug Delivery Technology Revenue in Global Market (2018-2023)
7.13.5 Novartis AG Key News & Latest Developments
7.14 OptiNose, Inc
7.14.1 OptiNose, Inc Company Summary
7.14.2 OptiNose, Inc Business Overview
7.14.3 OptiNose, Inc Nasal Drug Delivery Technology Major Product Offerings
7.14.4 OptiNose, Inc Nasal Drug Delivery Technology Revenue in Global Market (2018-2023)
7.14.5 OptiNose, Inc Key News & Latest Developments
7.15 PendoPharm, Inc
7.15.1 PendoPharm, Inc Company Summary
7.15.2 PendoPharm, Inc Business Overview
7.15.3 PendoPharm, Inc Nasal Drug Delivery Technology Major Product Offerings
7.15.4 PendoPharm, Inc Nasal Drug Delivery Technology Revenue in Global Market (2018-2023)
7.15.5 PendoPharm, Inc Key News & Latest Developments
7.16 Pfizer, Inc
7.16.1 Pfizer, Inc Company Summary
7.16.2 Pfizer, Inc Business Overview
7.16.3 Pfizer, Inc Nasal Drug Delivery Technology Major Product Offerings
7.16.4 Pfizer, Inc Nasal Drug Delivery Technology Revenue in Global Market (2018-2023)
7.16.5 Pfizer, Inc Key News & Latest Developments
7.17 Promius Pharma, LLC
7.17.1 Promius Pharma, LLC Company Summary
7.17.2 Promius Pharma, LLC Business Overview
7.17.3 Promius Pharma, LLC Nasal Drug Delivery Technology Major Product Offerings
7.17.4 Promius Pharma, LLC Nasal Drug Delivery Technology Revenue in Global Market (2018-2023)
7.17.5 Promius Pharma, LLC Key News & Latest Developments
7.18 Shin Nippon Biomedical Laboratories
7.18.1 Shin Nippon Biomedical Laboratories Company Summary
7.18.2 Shin Nippon Biomedical Laboratories Business Overview
7.18.3 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Major Product Offerings
7.18.4 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Revenue in Global Market (2018-2023)
7.18.5 Shin Nippon Biomedical Laboratories Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Nasal Drug Delivery Technology Market Opportunities & Trends in Global Market
Table 2. Nasal Drug Delivery Technology Market Drivers in Global Market
Table 3. Nasal Drug Delivery Technology Market Restraints in Global Market
Table 4. Key Players of Nasal Drug Delivery Technology in Global Market
Table 5. Top Nasal Drug Delivery Technology Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Nasal Drug Delivery Technology Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Nasal Drug Delivery Technology Revenue Share by Companies, 2018-2023
Table 8. Global Companies Nasal Drug Delivery Technology Product Type
Table 9. List of Global Tier 1 Nasal Drug Delivery Technology Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nasal Drug Delivery Technology Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Nasal Drug Delivery Technology Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Nasal Drug Delivery Technology Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Nasal Drug Delivery Technology Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Nasal Drug Delivery Technology Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Nasal Drug Delivery Technology Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Nasal Drug Delivery Technology Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Nasal Drug Delivery Technology Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Nasal Drug Delivery Technology Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Nasal Drug Delivery Technology Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Nasal Drug Delivery Technology Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Nasal Drug Delivery Technology Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Nasal Drug Delivery Technology Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Nasal Drug Delivery Technology Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Nasal Drug Delivery Technology Revenue, (US$, Mn), 2024-2032
Table 30. 3M United States Company Summary
Table 31. 3M United States Nasal Drug Delivery Technology Product Offerings
Table 32. 3M United States Nasal Drug Delivery Technology Revenue (US$, Mn) & (2018-2023)
Table 33. 3M United States Key News & Latest Developments
Table 34. Aegis Therapeutics LLC Company Summary
Table 35. Aegis Therapeutics LLC Nasal Drug Delivery Technology Product Offerings
Table 36. Aegis Therapeutics LLC Nasal Drug Delivery Technology Revenue (US$, Mn) & (2018-2023)
Table 37. Aegis Therapeutics LLC Key News & Latest Developments
Table 38. Aptargroup, Inc. Company Summary
Table 39. Aptargroup, Inc. Nasal Drug Delivery Technology Product Offerings
Table 40. Aptargroup, Inc. Nasal Drug Delivery Technology Revenue (US$, Mn) & (2018-2023)
Table 41. Aptargroup, Inc. Key News & Latest Developments
Table 42. Becton, Dickinson and Company Company Summary
Table 43. Becton, Dickinson and Company Nasal Drug Delivery Technology Product Offerings
Table 44. Becton, Dickinson and Company Nasal Drug Delivery Technology Revenue (US$, Mn) & (2018-2023)
Table 45. Becton, Dickinson and Company Key News & Latest Developments
Table 46. BF Ascher & Company, Inc. Company Summary
Table 47. BF Ascher & Company, Inc. Nasal Drug Delivery Technology Product Offerings
Table 48. BF Ascher & Company, Inc. Nasal Drug Delivery Technology Revenue (US$, Mn) & (2018-2023)
Table 49. BF Ascher & Company, Inc. Key News & Latest Developments
Table 50. Cadila Pharmaceuticals Ltd Company Summary
Table 51. Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Offerings
Table 52. Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue (US$, Mn) & (2018-2023)
Table 53. Cadila Pharmaceuticals Ltd Key News & Latest Developments
Table 54. Dickinson and Company Company Summary
Table 55. Dickinson and Company Nasal Drug Delivery Technology Product Offerings
Table 56. Dickinson and Company Nasal Drug Delivery Technology Revenue (US$, Mn) & (2018-2023)
Table 57. Dickinson and Company Key News & Latest Developments
Table 58. Douglas Pharmaceuticals Ltd Company Summary
Table 59. Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Offerings
Table 60. Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue (US$, Mn) & (2018-2023)
Table 61. Douglas Pharmaceuticals Ltd Key News & Latest Developments
Table 62. ENT Technologies Pty. Ltd Company Summary
Table 63. ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Product Offerings
Table 64. ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Revenue (US$, Mn) & (2018-2023)
Table 65. ENT Technologies Pty. Ltd Key News & Latest Developments
Table 66. Glaxosmithkline PLC Company Summary
Table 67. Glaxosmithkline PLC Nasal Drug Delivery Technology Product Offerings
Table 68. Glaxosmithkline PLC Nasal Drug Delivery Technology Revenue (US$, Mn) & (2018-2023)
Table 69. Glaxosmithkline PLC Key News & Latest Developments
Table 70. Johnson & Johnson Company Summary
Table 71. Johnson & Johnson Nasal Drug Delivery Technology Product Offerings
Table 72. Johnson & Johnson Nasal Drug Delivery Technology Revenue (US$, Mn) & (2018-2023)
Table 73. Johnson & Johnson Key News & Latest Developments
Table 74. Merck & Co., Inc. Company Summary
Table 75. Merck & Co., Inc. Nasal Drug Delivery Technology Product Offerings
Table 76. Merck & Co., Inc. Nasal Drug Delivery Technology Revenue (US$, Mn) & (2018-2023)
Table 77. Merck & Co., Inc. Key News & Latest Developments
Table 78. Novartis AG Company Summary
Table 79. Novartis AG Nasal Drug Delivery Technology Product Offerings
Table 80. Novartis AG Nasal Drug Delivery Technology Revenue (US$, Mn) & (2018-2023)
Table 81. Novartis AG Key News & Latest Developments
Table 82. OptiNose, Inc Company Summary
Table 83. OptiNose, Inc Nasal Drug Delivery Technology Product Offerings
Table 84. OptiNose, Inc Nasal Drug Delivery Technology Revenue (US$, Mn) & (2018-2023)
Table 85. OptiNose, Inc Key News & Latest Developments
Table 86. PendoPharm, Inc Company Summary
Table 87. PendoPharm, Inc Nasal Drug Delivery Technology Product Offerings
Table 88. PendoPharm, Inc Nasal Drug Delivery Technology Revenue (US$, Mn) & (2018-2023)
Table 89. PendoPharm, Inc Key News & Latest Developments
Table 90. Pfizer, Inc Company Summary
Table 91. Pfizer, Inc Nasal Drug Delivery Technology Product Offerings
Table 92. Pfizer, Inc Nasal Drug Delivery Technology Revenue (US$, Mn) & (2018-2023)
Table 93. Pfizer, Inc Key News & Latest Developments
Table 94. Promius Pharma, LLC Company Summary
Table 95. Promius Pharma, LLC Nasal Drug Delivery Technology Product Offerings
Table 96. Promius Pharma, LLC Nasal Drug Delivery Technology Revenue (US$, Mn) & (2018-2023)
Table 97. Promius Pharma, LLC Key News & Latest Developments
Table 98. Shin Nippon Biomedical Laboratories Company Summary
Table 99. Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Product Offerings
Table 100. Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Revenue (US$, Mn) & (2018-2023)
Table 101. Shin Nippon Biomedical Laboratories Key News & Latest Developments
List of Figures
Figure 1. Nasal Drug Delivery Technology Segment by Type in 2022
Figure 2. Nasal Drug Delivery Technology Segment by Application in 2022
Figure 3. Global Nasal Drug Delivery Technology Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nasal Drug Delivery Technology Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Nasal Drug Delivery Technology Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nasal Drug Delivery Technology Revenue in 2022
Figure 8. By Type - Global Nasal Drug Delivery Technology Revenue Market Share, 2018-2032
Figure 9. By Application - Global Nasal Drug Delivery Technology Revenue Market Share, 2018-2032
Figure 10. By Type - Global Nasal Drug Delivery Technology Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Nasal Drug Delivery Technology Revenue Market Share, 2018-2032
Figure 12. By Application - Global Nasal Drug Delivery Technology Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Nasal Drug Delivery Technology Revenue Market Share, 2018-2032
Figure 14. By Region - Global Nasal Drug Delivery Technology Revenue Market Share, 2018-2032
Figure 15. By Country - North America Nasal Drug Delivery Technology Revenue Market Share, 2018-2032
Figure 16. US Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Nasal Drug Delivery Technology Revenue Market Share, 2018-2032
Figure 20. Germany Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 21. France Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Nasal Drug Delivery Technology Revenue Market Share, 2018-2032
Figure 28. China Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 32. India Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Nasal Drug Delivery Technology Revenue Market Share, 2018-2032
Figure 34. Brazil Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Nasal Drug Delivery Technology Revenue Market Share, 2018-2032
Figure 37. Turkey Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Nasal Drug Delivery Technology Revenue, (US$, Mn), 2018-2032
Figure 41. 3M United States Nasal Drug Delivery Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Aegis Therapeutics LLC Nasal Drug Delivery Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Aptargroup, Inc. Nasal Drug Delivery Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Becton, Dickinson and Company Nasal Drug Delivery Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. BF Ascher & Company, Inc. Nasal Drug Delivery Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Dickinson and Company Nasal Drug Delivery Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Glaxosmithkline PLC Nasal Drug Delivery Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Johnson & Johnson Nasal Drug Delivery Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Merck & Co., Inc. Nasal Drug Delivery Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Novartis AG Nasal Drug Delivery Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. OptiNose, Inc Nasal Drug Delivery Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. PendoPharm, Inc Nasal Drug Delivery Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Pfizer, Inc Nasal Drug Delivery Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Promius Pharma, LLC Nasal Drug Delivery Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
